Programmed Death-Ligand 1 as a prognostic marker in papillary thyroid cancer

被引：0
|
作者：
Ellis, Ryan J. [1 ]
Boufraqech, Myriem [1 ]
Jain, Meenu [1 ]
Patel, Dhaval [1 ]
Nilubol, Naris [1 ]
He, Mei [1 ]
Zhang, Lisa [1 ]
Kebebew, Electron [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2013年 / 217卷 / 03期
关键词：
D O I：
10.1016/j.jamcollsurg.2013.07.053
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 50 条
  • [1] Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants
    Chowdhury, Subrata
    Veyhl, Joe
    Jessa, Fatima
    Polyakova, Olena
    Alenzi, Ahmed
    MacMillan, Christina
    Ralhan, Ranju
    Walfish, Paul G.
    ONCOTARGET, 2016, 7 (22) : 32318 - 32328
  • [2] PROGRAMMED CELL DEATH-LIGAND 1 OVEREXPRESSION IN THYROID CANCER
    Zhang, Guo-Qiang
    Wei, Wei-Jun
    Song, Hong-Jun
    Sun, Zhen-Kui
    Shen, Chen-Tian
    Zhang, Xin-Yun
    Chen, Xiao-Yue
    Qiu, Zhong-Ling
    Luo, Quan-Yong
    ENDOCRINE PRACTICE, 2019, 25 (03) : 279 - 286
  • [3] Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence
    Shi, Rong-liang
    Qu, Ning
    Luo, Ting-xian
    Xiang, Jun
    Liao, Tian
    Sun, Guo-hua
    Wang, Yu
    Wang, Yu-long
    Huang, Cai-ping
    Ji, Qing-hai
    THYROID, 2017, 27 (04) : 537 - 545
  • [4] Programmed Death-Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC
    Ancel, Julien
    Birembaut, Philippe
    Dewolf, Maxime
    Durlach, Anne
    Nawrocki-Raby, Beatrice
    Dalstein, Veronique
    Delepine, Gonzague
    Blacher, Silvia
    Deslee, Gaetan
    Gilles, Christine
    Polette, Myriam
    CANCERS, 2019, 11 (10)
  • [5] Role of Programmed Death-Ligand 1 in Cancer
    Link, Tina
    Dilip, Megha
    Caruso, Olivia
    Chang, Margaret
    Kona, Abhinav
    Liu, Jesse
    Nathan, Ajay
    Singh, Anita
    Thomas-Wilkinson, Shiloh
    FASEB JOURNAL, 2019, 33
  • [6] The Prognostic Role of Programmed Death-Ligand 1 in Nasopharyngeal Carcinoma
    Wotman, Michael
    Herman, Saori W.
    Costantino, Peter
    Tham, Tristan
    LARYNGOSCOPE, 2020, 130 (11): : 2598 - 2606
  • [7] Programmed Death-Ligand 1 Expression and Its Correlation with Lymph Node Metastasis in Papillary Thyroid Carcinoma
    An, Hyo Jung
    Ko, Gyung Hyuck
    Lee, Jeong-Hee
    Lee, Jong Sil
    Kim, Dong Chul
    Yang, Jung Wook
    Kim, Min Hye
    Kim, Jin Pyeong
    Jung, Eun Jung
    Song, Dae Hyun
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2018, 52 (01) : 9 - 13
  • [8] Programmed death-ligand 1 expression in rectal cancer
    Jomrich, G.
    Silberhumer, G. R.
    Marian, B.
    Beer, A.
    Muellauer, L.
    EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, 2016, 48 (06): : 352 - 356
  • [9] Programmed death-ligand 1 expression in rectal cancer
    G. Jomrich
    G. R. Silberhumer
    B. Marian
    A. Beer
    L. Müllauer
    European Surgery, 2016, 48 : 352 - 356
  • [10] The clinicopathological and prognostic value of programmed death-ligand 1 in colorectal cancer: a meta-analysis
    Ni, X.
    Sun, X.
    Wang, D.
    Chen, Y.
    Zhang, Y.
    Li, W.
    Wang, L.
    Suo, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (05): : 674 - 686
12345